The development and appraisal of a tool designed to find patients harmed by falsely labelled, falsified (counterfeit) medicines
Abstract Background Falsely labelled, falsified (counterfeit) medicines (FFCm's) are produced or distributed illegally and can harm patients. Although the occurrence of FFCm's is increasing in Europe, harm is rarely reported. The European Directorate for the Quality of Medicines & Heal...
Saved in:
Main Authors: | Marija Anđelković (Author), Einar Björnsson (Author), Virgilio De Bono (Author), Nenad Dikić (Author), Katleen Devue (Author), Daniel Ferlin (Author), Miroslav Hanževački (Author), Freyja Jónsdóttir (Author), Mkrtich Shakaryan (Author), Sabine Walser (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2017-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combatting Substandard and Falsified Medicines: Public Awareness and Identification of Counterfeit Medications
by: Faris El-Dahiyat, et al.
Published: (2021) -
Combating Sale of Counterfeit and Falsified Medicines Online: A Losing Battle
by: Kah Seng Lee, et al.
Published: (2017) -
Commentary: Combating Sale of Counterfeit and Falsified Medicines Online: A Losing Battle
by: Baobin Huang, et al.
Published: (2017) -
A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country
by: Daariimaa Khurelbat, et al.
Published: (2020) -
Development and initial validation of a postal survey evaluation of community pharmacists' opinion regarding falsified (counterfeit) medicines in Hampshire (UK)
by: Ravina Barrett, et al.
Published: (2018)